Cargando…
MUC16 stimulates neutrophils to an inflammatory and immunosuppressive phenotype in ovarian cancer
BACKGROUND: MUC16 (CA125) is a commonly used tumor marker for ovarian cancer screening and reported to be an immunosuppressive factor by acting on the sialic acid-binding immunoglobulin-like lectin-9 (Siglec-9) on the surface of natural killer cells (NK cells), B cells, and monocytes. However, the r...
Autores principales: | Wu, Yuliang, Liu, Qi, Xie, Yan, Zhu, Jihui, Zhang, Sai, Ge, Yao, Guo, Jing, Luo, Ning, Huang, Wei, Xu, Runping, Liu, Shupeng, Cheng, Zhongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466733/ https://www.ncbi.nlm.nih.gov/pubmed/37644468 http://dx.doi.org/10.1186/s13048-023-01207-0 |
Ejemplares similares
-
Inflammatory signals induce MUC16 expression in ovarian cancer cells via NF-κB activation
por: Liu, Jie, et al.
Publicado: (2021) -
Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas
por: Huang, Wei, et al.
Publicado: (2023) -
Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer
por: Jain, Shruti, et al.
Publicado: (2022) -
LPS and IL-8 activated umbilical cord blood-derived neutrophils inhibit the progression of ovarian cancer
por: Liu, Qi, et al.
Publicado: (2020) -
Identification of TRPM2 as a prognostic factor correlated with immune infiltration in ovarian cancer
por: Huang, Wei, et al.
Publicado: (2023)